Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115894345A reveals a metal-free visible light method for chiral azaarene cyclobutanes, offering cost reduction in API manufacturing and high stereoselectivity.
Novel one-pot process for NOR-type HALS improves yield and reduces steps for polymer additive supply chains globally ensuring high purity and efficiency.
Patent CN106146306A reveals a metal-free organocatalytic route for axial chiral biaryl compounds, offering significant cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN114807246A details high-efficiency enzymatic reduction for chiral alcohols, offering superior stereoselectivity and industrial scalability for pharmaceutical intermediates.
Advanced synthesis patent CN100348601C enables high-purity sodium phosphate nucleating agents. Streamlined phase transfer catalysis reduces costs and ensures supply chain reliability for polymer manufacturers.
Discover the scalable synthesis of imidazopyridine intermediates for P2X3 antagonists. This patent offers mild conditions and high purity for reliable pharmaceutical supply chains.
Novel enzyme mutant technology enables green cordycepin production. Reduces cost and improves supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN110452942B reveals a cost-effective immobilized enzyme method for D-ribulose, offering significant supply chain stability and reduced manufacturing costs for pharmaceutical intermediates.
Patent CN101659620A details a green route for 2,5-diaminotoluene using magnetic catalysts. Discover cost-effective, high-purity manufacturing solutions for global supply chains.
Novel one-step synthesis method reduces cost and improves purity for palladium catalyst manufacturing supply chain reliability ensuring consistent high-quality delivery.
Patent CN1599743A discloses novel tropp ligands enabling high-efficiency asymmetric hydrogenation. Ideal for pharmaceutical intermediate manufacturing with reduced costs.
Patent CN102250976A reveals an enzymatic route for chiral tert-leucine. Achieve >99% ee and significant cost reduction in pharmaceutical intermediate manufacturing with scalable green chemistry.
Patent CN118515620A details a heterogeneous Pd/ACFs catalytic method for high-purity quinazolinone synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel immobilized cell method ensures high purity and cost efficiency for pharmaceutical intermediates manufacturing supply chains.
Novel lipase mutant enables efficient synthesis of chiral intermediates. Reduces solvent use and enhances supply chain reliability for global pharmaceutical manufacturing.
Patent CN103468757A details a green enzymatic reduction for Atazanavir intermediates, offering high purity and safer manufacturing for pharmaceutical supply chains.
Patent CN109251948B reveals enzymatic synthesis for D-erythrulose. Offers cost reduction and supply chain reliability for personal care chemical manufacturing.
Novel one-pot method for (5-bromo-2-chlorophenyl)(4-ethoxyphenyl)methanone. High purity, reduced steps, eco-friendly process for API manufacturing.
Patent CN1182125C details a robust route for (2R,2-alpha-R,3a)-2-[1-(3,5-bis(trifluoromethyl)phenyl)ethoxy]-3-(4-fluorophenyl)-1,4-oxazine, offering superior yield and purity for pharmaceutical supply chains.
Patent CN102584800A details an asymmetric synthesis of chiral indolinone-angelica lactone frameworks using cinchona alkaloid catalysis, offering high enantioselectivity for pharmaceutical intermediates.